Cimicifuga Rhizome, originated from a rhizome of the genus Cimicifuga plants, have been used as anti-inflammatory, analgesic and antipyretic remedies in Chinese traditional medicine. Cimicifuga species have been extensively investigated and many cycloartane glycosides have been isolated.
1
H-NMR data of 1 was similar to those of cycloartane glycoside from Cimicifuga acerina and C. simplex. The compound was identical with cimiaceroside B by comparing its physical and spectra data with literature values. 4) Compound (2) H-NMR data of 1 was similar to those of compound 1. In the 1 H-and 13 C-NMR spectra of 2, the signals due to the aglycone moiety were in good agreement with those of 1, although the signals due to the sugar moiety were not identical. On acid hydrolysis, 2 afforded Dglucose and D-xylose whose structures were confirmed by 1 . These evidence suggested that its sugar moiety was composed of a glucosyl-glucosyl-xylosyl unit. The NMR data could be assigned with the aid of 1 H-1 H correlation spectroscopy (COSY), heteronuclear multiple quantum coherence (HMQC), total correlation spectroscopy (TOCSY) and heteronuclear multiple bond correlation spectroscopy (HMBC) experiments. In the HMBC experiment, the anomeric proton signals at 5) The NMR spectra of 3 were essentially analogous with those of 2 and suggestive of a cycloartane glycoside of the same type. In the meantime, the negative FAB-MS of 3 gave a peak at m/z 1119 due to [ . These evidences suggested the composition of an isoferuloyl-glucosylglucosyl-xylosyl unit. In the 1 H-NMR spectra of 3, the signal due to the terminal glucose H-6ٞ was shifted downfield by 0.60 and 0.63, as compared with those of 2 to appear at (Fig. 2) . Thus, the structure of 3 was elucidated.
As previously reported , the presence of a large number of cycloartane glycosides, possessing a monosaccharide unit, was a common feature of the genus Cimicifuga plants. 1) We now have described for the first time a cycloartane glycoside possessing a trisaccharide unit. Furthermore, compounds 1-3 were evaluated for their immunosuppressive activity in mouse allogeneic mixed lymphocyte reaction.
2) These compounds suppressed the proliferation of lymphocytes and the 50% inhibitory concentrations (IC 50 ) were calculated from Ϫ5 M, respectively). Immunosuppressive activity of 1-3 was much of the same value, independent of the sugar moiety.
Experimental
Optical rotations were taken with a JASCO DIP-1000 automatic digital polarimeter. The NMR spectra were measured with a JEOL alpha 500 NMR spectrometer and chemical shifts are given on a d (ppm) scale with tetramethylsilane (TMS) as an internal standard. The FAB-MS was recorded with a JEOL HX-110 spectrometer. HPLC was carried out using a TSK gel-120A (7.8 mm i.d.ϫ30 cm) column with a Tosoh CCPM pump, Tosoh RI-8010 detector and JASCO OR-2090 detector. Absorbance spectra were recorded on a Bio-Rad Microplate Reader Model 550. TLC was performed on pre-coated Kieselgel 60 F 254 (Merck), and detection was achieved by spraying with 10% H 2 SO 4 followed by heating. Column chromatography was carried out on Kieselgel (230-400 mesh, Merck), Sephadex-LH20 (Pharmacia Find Chem. Co. Ltd.) and MCI gel CHP20P (Mitsubishi Chemical Ind.).
Plant Material Cimicifuga Rhizome was purchased from Uchida Wakanyaku Co., Ltd. This dried rhizome originated from Heilungkiang Province in China.
Extraction and Isolation Cimicifuga Rhizome (20 kg) was extracted with MeOH at room temperature for six months. The MeOH extract (2 kg) was partitioned between chloroform-soluble (1046 g), water-soluble (941 g) and insoluble (12 g) portions. The insoluble portion was subjected to MCI gel CHP20P column chromatography with MeOH-H 2 O (50®60®70® 80®90%) to afford ten fractions (fr. 1-fr. 10). Fraction 4 (334 mg) was further separated by Sephadex-LH20 column chromatography with MeOH to afford two fractions (fr. 11-fr. 12). Fraction 11 was subjected to silica gel column chromatography with CHCl 3 -MeOH-H 2 O (7 : 3 : 0.5), followed by HPLC with MeOH-H 2 O (3 : 1), to furnish compound 2 (10 mg). Fraction 5 (305 mg) was further separated by Sephadex-LH20 column chromatography with MeOH to afford two fractions (fr. 13-fr. 14). Fraction 14 was subjected to silica gel column chromatography with CHCl 3 -MeOH-H 2 O (9 : 1 : 0.1), followed by HPLC with MeOH-H 2 O (7 : 3), to furnish compound 3 (6 mg). Fraction 9 (961 mg) was further separated by silica gel column chromatography with CHCl 3 -MeOH-H 2 O (9 : 1 : 0.1) to afford three fractions (fr. 15-fr. 17). Fraction 16 was subjected to HPLC with MeOH-H 2 O (4 : 1), to furnish compound 1 (24 mg). 
